InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
-0.25%
)
US TECH 100
19,244.80
(
-0.07%
)
Dow Jones
39,134.76
(
0.00%
)
Brent Oil
84.86
(
-0.17%
)
Bitcoin
63,772.00
(
-1.62%
)
Post# of 58465
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

The Holder

Send PM Follow Ignore
Followers 14
Posts 1160
Boards Moderated 0
Alias Born 12/19/2008

The Holder

Re: None

Tuesday, 04/21/2009 3:36:10 PM

Tuesday, April 21, 2009 3:36:10 PM

Post# of 58465
The EMEA can't approve the drug...

...until the trial is complete and shows significant confirmatory evidence of the 1st trial results in participants with normal to low LDH values.

Those data will not be available until 6 months from now at the earliest. Genta will have to reverse split before that timeframe.

Sorry, don't be mislead by others who will capitalize on those who haven't done research on the subject.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up